Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered lactobacillus plantarum in rodents

Hepatology

Volumn 48, Issue 4, 2008, Pages 1184-1192

  Nicaise, Charles ^a   Prozzi, Deborah ^b   Viaene, Eric ^b   Moreno, Christophe ^a,c   Gustot, Thierry ^a,c   Quertinmont, Eric ^a   Demetter, Pieter ^c   Suain, Valérie ^a   Goffin, Philippe ^b   Devière, Jacques ^a,c   Hols, Pascal ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CARBON TETRACHLORIDE; LACTULOSE; ORNITHINE CARBAMOYLTRANSFERASE; PROBIOTIC AGENT; THIOACETAMIDE; ALANINE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BACTERIAL STRAIN; BRAIN CORTEX; CELL SWELLING; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE CONTROL; FECES ANALYSIS; GENETIC ENGINEERING; HYPERAMMONEMIA; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; LIVER FAILURE; LIVER INJURY; MALE; MICROBIOLOGICAL EXAMINATION; MOUSE; NONHUMAN; PH; PLASMID; PRIORITY JOURNAL; RODENT; SURVIVAL; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DIET THERAPY; DISEASE MODEL; GENETICS; LEWIS RAT; METABOLISM; RAT;

ACUTE DISEASE; ALANINE; AMMONIA; ANIMALS; CARBON TETRACHLORIDE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HYPERAMMONEMIA; LACTOBACILLUS PLANTARUM; LACTULOSE; LIVER FAILURE; MALE; MICE; MICE, INBRED C57BL; PROBIOTICS; RATS; RATS, INBRED LEW; THIOACETAMIDE;

EID: 54449084634     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22445     Document Type: Article

References (43)

1. Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 2001; 96:1968-1976.
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002;35:716-721.
3. Brusilow SW. Hyperammonemic encephalopathy. Medicine 2002;81:240-249.
4. Lewis M, Howdle PD. The neurology of liver failure. Q J Med 2003;96: 623-633.
5. Butterworth RF. Hepatic encephalopathy. Alcohol Res Health 2003;27: 240-246.
6. Lockwood AH, Yap EWH, Wong WH. Cerebral ammonia metabolism in patients with severe liver-disease and minimal hepatic-encephalopathy. J Cereb Blood Flow Metab 1991;11:337-341.
7. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34:768-773.
8. Kundra A, Jain A, Banga A, Bajaj G, Kar P. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. Clin Biochem 2005;38:696-699.
9. Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 2006;55:98-104.
10. Itzhak Y, Roig-Cantisano A, Dombro RS, Norenberg MD. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995;705:345-348.
11. Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel JM, et al. Hepatocyte transplantation in rats with decompensated cirrhosis. HEPATOLOGY 2000;31:851-857.
12. D'hooge R, Marescau B, Qureshi IA, De Deyn PP. Impaired cognitive performance in ornithine transcarbamylase-deficient mice on arginine-free diet. Brain Res 2000;876:1-9.
13. Katayama K. Ammonia metabolism and hepatic encephalopathy. Hepatol Res 2004;30:S73-S80.
14. Manning TS, Gibson GR. Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol 2004;18:287-298.
15. Mortensen PB, Holtug K, Bonnen H, Clausen MR. The degradation of amino-acids, proteins, and blood to short-chain fatty-acids in colon is prevented by lactulose. Gastroenterology 1990;98:353-360.
16. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473-479.
17. Shawcross D, Jalan R. Dispelling myths in the treatment of hepatic encephalopathy. Lancet 2005;365:431-433.
18. Shawcross DL, Jalan R. Treatment of hepatic encephalopathy - It's not lactulose. Br Med J 2004;329:112.
19. 3 and phenols [Abstract]. Gastroenterology 2006;130:A745.
20. Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003;61:307-313.
21. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. HEPATOLOGY 2004;39:1441-1449.
22. Jia L, Zhang MH. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World J Gastroenterol 2005; 11:908-911.
23. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73(2 Suppl):430S-436S.
24. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 2000;119:305-309.
25. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001;152:735-741.
26. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000;31:453-457.
27. Maassen CB, Laman JD, van Holten-Neelen C, Hoogteijling L, Groenewegen L, Visser L, et al. Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens. Vaccine 2003;21:4685-4693.
28. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-1355.
29. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, et al. A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006;4:754-759.
30. Aukrust T, Blom H. Transformation of Lactobacillus strains used in meat and vegetable fermentations. Food Res Int 1992;25:253-261.
31. Goffin P, Deghorain M, Mainardi JL, Tytgat I, Champomier-Verges MC, Kleerebezem M, et al. Lactate racemization as a rescue pathway for supplying D-lactate to the cell wall biosynthesis machinery in Lactobacillus plantarum. J Bacteriol 2005;187:6750-6761.
32. Matkowskyj KA, Marrero JA, Carroll RE, Danilkovich AV, Green RM, Benya RV. Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am J Physiol 1999;277: G455-G462.
33. Macbeth WA, Kass EH, McDermott WV. Treatment of hepatic encephalopathy by alteration of intestinal flora with Lactobacillus acidophilus. Lancet 1965;1:399-403.
34. Read AE, McCarthy CF, Heaton KW, Laidlaw J. Lactobacillus acidophilus (Enpac) in treatment of hepatic encephalopathy. Br Med J 1966;1: 1267-1269.
35. Loguercio C, Abbiati R, Rinaldi M, Romano A, Blanco CD, Coltorti M. Long-term effects of Enterococcus faecium Sf68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic-encephalopathy. J Hepatol 1995;23:39-46.
36. 3 bidirectionally. Proc Natl Acad Sci U S A 2002;99:3926-3931.
37. Soupene E, He LH, Yan DL, Kustu S. Ammonia acquisition in enteric bacteria: Physiological role of the ammonium/methylammonium transport B (AmtB) protein. Proc Natl Acad Sci U S A 1998;95:7030-7034.
38. Nygaard TP, Rovira C, Peters GH, Jensen MO. Ammonium recruitment and ammonia transport by E. coli ammonia channel AmtB. Biophys J 2006;91:4401-4412.
39. 3: Molecular dynamics simulations. Biophys J 2006;92:875-885.
40. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol 2006;72:5799-5805.
41. Steidler L. Genetically engineered probiotics. Best Pract Res Clin Gastroenterol 2003;17:861-876.
42. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 2005; 102:10321-10326.
43. Ladero V, Ramos A, Wiersma A, Goffin P, Schanck A, Kleerebezem M, et al. High-level production of the low-calorie sugar sorbitol by Lactobacillus plantarum through metabolic engineering. Appl Environ Microbiol 2007; 73:1864-1872.